2024-02-08 16:39:01 ET
More on Curis
- Curis, Inc. (CRIS) Q4 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Curi s
Read the full article on Seeking Alpha
For further details see:
Curis files for $300M common stock offering2024-02-08 16:39:01 ET
Read the full article on Seeking Alpha
For further details see:
Curis files for $300M common stock offeringMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024 PR Newswire LEXINGTON, Mass. , April 30, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 62.9% to $0.0373 on volume of 466,310,671 shares INVO BioScience Inc. (INVO) rose 139.5% to $1.82 on volume of 225,666,770 shares PROSHARES TRUST (SQQQ) rose 3.7% to $11.86 on volume of 167,545,988 ...
As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in ...